Stereotaxis, Inc. (STXS) Financials

STXS Assets vs Liabilities
DateAssetsLiabilities
June 30, 2026 55.6 million 38.1 million
March 31, 2026 54.0 million 34.4 million
Dec. 31, 2025 52.3 million 33.5 million
Sept. 30, 2025 45.6 million 34.1 million

STXS Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
June 30, 2026 -3.7 million 1.6 million
March 31, 2026 -3.5 million 2.1 million
Dec. 31, 2025 -4.0 million 2.4 million
Sept. 30, 2025 -4.2 million 2.5 million

STXS Net Income

No data available :(

STXS Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
June 30, 2026 10.5 million - 5.2 million
March 31, 2026 14.6 million - 5.3 million
Dec. 31, 2025 13.4 million - 5.4 million
Sept. 30, 2025 10.5 million - 5.6 million

STXS Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
June 30, 2026 100.0 million
March 31, 2026 98.9 million
Dec. 31, 2025 96.0 million
Sept. 30, 2025 92.0 million

STXS Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
June 30, 2026 64000 2.4 million 6.7 million 2.6 million
March 31, 2026 79000 2.4 million 7.4 million 2.6 million
Dec. 31, 2025 70000 2.7 million 7.3 million 3.1 million
Sept. 30, 2025 - 2.5 million 8.1 million 2.9 million

STXS Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
June 30, 2026 7.7 million 3.2 million
March 31, 2026 6.3 million 2.5 million
Dec. 31, 2025 8.6 million 4.3 million
Sept. 30, 2025 7.5 million 3.4 million

STXS Revenue by Segment
Graph available only for paid members. Upgrade to see it.

STXS

Price: $1.01

52 week price:
1.01
3.59

Earnings Per Share: -0.24 USD

Exchange: ASE

Sector: Healthcare

Industry: Medical Instruments & Supplies

Country: United States

Volume: 50343

Ebitda: -5.0 million

Market Capitalization: 115.6 million

Links: